FDA Cites GlaxoSmithKline for Problems With SOPs

Drug Industry Daily
A A
The FDA cited GlaxoSmithKline’s East Durham, New York facility for failing to follow standard operating procedures.

To View This Article:

Login

Subscribe To Drug Industry Daily